The GLP-1 compound drug sold by Hims and Hers is not approved by the FDA and its Super Bowl ad fails to list any risks ...

Patients with chronic obstructive pulmonary disease, interstitial lung disease and pulmonary hypertension experience improved ...

PEPFAR, the main U.S.-funded global AIDS program was given a waiver from the foreign aid freeze, but there is still ...

Study results show that genetic sensitivity to stress was linked to a 49% higher risk of lung cancer in people of European ...

Women are more likely to have pulmonary arterial hypertension, but men tend to have worse outcomes and worse treatment responses.

Treosulfan (Grafapex) was approved in Canada in June 2021 for the same use and is marketed under the brand name Trecondyv.

The technology to leverage healthcare data exists. The problem, according to Highlander Health, is outdated structures and ...

Laurie Ratliff was diagnosed with metastatic breast cancer 25 years ago, and she’s continuing to beat the odds while ...

The quality-adjusted life years has shown staying power in cost-effectiveness calculations, but some say it has major flaws ...

Gossamer Bio Inc. has released new data showing its inhaled kinase inhibitor, seralutinib, has long-lasting effects on ...

The biggest challenge in training the next generation of respiratory therapists is getting them to engage in "critical ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...